EP0460064A4 - Therapeutic aerosol formulations - Google Patents

Therapeutic aerosol formulations

Info

Publication number
EP0460064A4
EP0460064A4 EP19900904101 EP90904101A EP0460064A4 EP 0460064 A4 EP0460064 A4 EP 0460064A4 EP 19900904101 EP19900904101 EP 19900904101 EP 90904101 A EP90904101 A EP 90904101A EP 0460064 A4 EP0460064 A4 EP 0460064A4
Authority
EP
European Patent Office
Prior art keywords
aerosol formulations
therapeutic aerosol
therapeutic
formulations
aerosol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19900904101
Other versions
EP0460064A1 (en
Inventor
George Robert 1485 Ashford Avenue Felt
Mark Peter Warchol
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rorer International Holdings Inc
Original Assignee
Rorer International Holdings Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rorer International Holdings Inc filed Critical Rorer International Holdings Inc
Publication of EP0460064A1 publication Critical patent/EP0460064A1/en
Publication of EP0460064A4 publication Critical patent/EP0460064A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
EP19900904101 1989-02-23 1990-02-21 Therapeutic aerosol formulations Withdrawn EP0460064A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31460589A 1989-02-23 1989-02-23
US314605 1994-09-28

Publications (2)

Publication Number Publication Date
EP0460064A1 EP0460064A1 (en) 1991-12-11
EP0460064A4 true EP0460064A4 (en) 1992-04-01

Family

ID=23220626

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19900904101 Withdrawn EP0460064A4 (en) 1989-02-23 1990-02-21 Therapeutic aerosol formulations

Country Status (6)

Country Link
EP (1) EP0460064A4 (en)
JP (1) JPH05508616A (en)
AU (1) AU5194990A (en)
CA (1) CA2050905A1 (en)
FI (1) FI913899A0 (en)
WO (1) WO1990009781A1 (en)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0562125A4 (en) * 1991-10-11 1994-03-18 Toray Industries Antibody composition.
CA2127877A1 (en) * 1992-01-21 1993-07-22 Robert M. Platz Improved process for preparing micronized polypeptide drugs
US6582728B1 (en) * 1992-07-08 2003-06-24 Inhale Therapeutic Systems, Inc. Spray drying of macromolecules to produce inhaleable dry powders
US5698672A (en) * 1995-04-04 1997-12-16 Zymogenetics, Inc. Synthetic calcitonin mimetics
GB9612297D0 (en) * 1996-06-11 1996-08-14 Minnesota Mining & Mfg Medicinal aerosol formulations
DE19733651A1 (en) * 1997-08-04 1999-02-18 Boehringer Ingelheim Pharma Aqueous aerosol preparations containing biologically active marrow molecules and processes for producing corresponding aerosols
GB9807232D0 (en) * 1998-04-03 1998-06-03 Univ Cardiff Aerosol composition
US6136294C1 (en) * 1998-09-22 2002-09-24 Aeropharm Technology Inc Amino acid stabilized medical aerosol formulation
US6458338B1 (en) * 1998-09-22 2002-10-01 Aeropharm Technology Incorporated Amino acid stabilized medicinal aerosol formulations
US6540983B1 (en) 2000-01-25 2003-04-01 Aeropharm Technology Incorporated Medical aerosol formulation
US6585957B1 (en) 2000-01-25 2003-07-01 Aeropharm Technology Incorporated Medicinal aerosol formulation
US6540982B1 (en) 2000-01-25 2003-04-01 Aeropharm Technology Incorporated Medical aerosol formulation
US6464959B1 (en) 2000-05-01 2002-10-15 Aeropharm Technology Incorporated Non-aqueous aerosol suspension comprising troglitazone, a fluid propellant, and an amino acid stabilizer
US6468507B1 (en) 2000-05-01 2002-10-22 Aeropharm Technology, Inc. Non-aqueous aerosol formulation comprising rosiglitazone maleate, a non-aqueous carrier, and an amino acid stabilizer
US6548049B1 (en) 2000-05-01 2003-04-15 Aeropharm Technology Incorporated Medicinal aerosol formulation
US6565833B1 (en) 2000-05-01 2003-05-20 Aeropharm Technology Incorporated Medicinal aerosol formulation
US6749845B2 (en) 2001-02-15 2004-06-15 Aeropharm Technology, Inc. Modulated release particles for lung delivery
US7176278B2 (en) 2001-08-30 2007-02-13 Biorexis Technology, Inc. Modified transferrin fusion proteins
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
WO2009015037A2 (en) 2007-07-21 2009-01-29 Albany Molecular Research, Inc. 5-pyridinone substituted indazoles
EP2628727A3 (en) 2007-11-21 2013-12-25 Decode Genetics EHF Biaryl PDE4 inhibitors for treating pulmonary and cardiovascular disorders
EP2077132A1 (en) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Dispensing device, storage device and method for dispensing a formulation
AU2009204048B2 (en) 2008-01-11 2013-08-01 Albany Molecular Research, Inc. (1-azinone) -substituted pyridoindoles as MCH antagonists
US8297305B2 (en) 2008-01-28 2012-10-30 Kohler Co. Valve assembly having an improved flow path
WO2010059836A1 (en) 2008-11-20 2010-05-27 Decode Genetics Ehf Substituted aza-bridged bicyclics for cardiovascular and cns disease
RU2506266C2 (en) 2009-01-26 2014-02-10 Израэл Инститьют Фо Байолоджикал Рисерч Bicyclic heterocyclic spirocompounds
US10011906B2 (en) 2009-03-31 2018-07-03 Beohringer Ingelheim International Gmbh Method for coating a surface of a component
EP3508239B1 (en) 2009-05-18 2020-12-23 Boehringer Ingelheim International GmbH Adapter, inhalant apparatus and atomizer
EP2504051B1 (en) 2009-11-25 2019-09-04 Boehringer Ingelheim International GmbH Nebulizer
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
JP5715640B2 (en) 2009-11-25 2015-05-13 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Nebulizer
EP2585151B1 (en) 2010-06-24 2018-04-04 Boehringer Ingelheim International GmbH Nebulizer
EP2694220B1 (en) 2011-04-01 2020-05-06 Boehringer Ingelheim International GmbH Medical device comprising a container
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
WO2013152894A1 (en) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Atomiser with coding means
WO2015018904A1 (en) 2013-08-09 2015-02-12 Boehringer Ingelheim International Gmbh Nebulizer
EP2835146B1 (en) 2013-08-09 2020-09-30 Boehringer Ingelheim International GmbH Nebulizer
HUE055604T2 (en) 2014-05-07 2021-12-28 Boehringer Ingelheim Int Nebulizer
BR112016023932B1 (en) 2014-05-07 2022-11-29 Boehringer Ingelheim International Gmbh NEBULIZER
JP6580070B2 (en) 2014-05-07 2019-09-25 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Container, nebulizer, and use
JP2021518413A (en) 2018-03-20 2021-08-02 アイカーン スクール オブ メディシン アット マウント サイナイ Kinase inhibitor compounds and compositions and usage
JP2021536467A (en) 2018-09-06 2021-12-27 インノファーマスクリーン インコーポレイテッド Methods and compositions for the treatment of asthma or Parkinson's disease
EP3906233B1 (en) 2018-12-31 2024-01-31 Icahn School of Medicine at Mount Sinai Kinase inhibitor compounds and compositions and methods of use

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB837465A (en) * 1957-01-31 1960-06-15 Riker Laboratories Inc Self-propelling, powder-dispensing compositions
GB994734A (en) * 1962-10-30 1965-06-10 Riker Laboratories Inc Self-propelling powder-dispensing compositions
EP0302772A1 (en) * 1987-08-03 1989-02-08 Asahi Kasei Kogyo Kabushiki Kaisha Calcitonin composition for nasal administration

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4241051A (en) * 1977-11-04 1980-12-23 Christie Robert B Calcitonin
JPS60161924A (en) * 1984-02-01 1985-08-23 Fujisawa Pharmaceut Co Ltd Composition for lung absorption
JPS61267528A (en) * 1984-11-26 1986-11-27 Yamanouchi Pharmaceut Co Ltd Transnasal calcitonin agent containing absorbefacient
WO1986006959A1 (en) * 1985-05-22 1986-12-04 Liposome Technology, Inc. Liposome inhalation method and system
HUT44794A (en) * 1985-12-04 1988-04-28 Sandoz Ag Process for production of calcitonine-derivatives and medical preparatives containing such compounds

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB837465A (en) * 1957-01-31 1960-06-15 Riker Laboratories Inc Self-propelling, powder-dispensing compositions
GB994734A (en) * 1962-10-30 1965-06-10 Riker Laboratories Inc Self-propelling powder-dispensing compositions
EP0302772A1 (en) * 1987-08-03 1989-02-08 Asahi Kasei Kogyo Kabushiki Kaisha Calcitonin composition for nasal administration

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
K. PARKITT et al.: "MARTINDALE - THE EXTRA PHARMACOPOEIA", Twenty-ninth edition, edited by J.E.F. Reynolds, January 1989, The Pharmaceutical Press, London, GB; *
PATENT ABSTRACTS OF JAPAN, vol. 9, no. 331 (C-321)(2054), 25th December 1985; & JP-A-60 161 924 (FUJISAWA YAKUHIN KOGYO K.K.) 23-08-1985 *
See also references of WO9009781A1 *

Also Published As

Publication number Publication date
AU5194990A (en) 1990-09-26
WO1990009781A1 (en) 1990-09-07
EP0460064A1 (en) 1991-12-11
CA2050905A1 (en) 1990-08-24
JPH05508616A (en) 1993-12-02
FI913899A0 (en) 1991-08-19

Similar Documents

Publication Publication Date Title
EP0460064A4 (en) Therapeutic aerosol formulations
GB8921222D0 (en) Medicinal aerosol formulations
GB8828477D0 (en) Medical aerosol formulations
ZA914957B (en) Aerosol drug formulations
EP0366277A3 (en) Pharmaceutical formulations
GB8908250D0 (en) Formulations
ZA902519B (en) Pharmaceutical formulations
AP9000174A0 (en) Antiparasitical formulations
GB8920348D0 (en) Medicinal aerosol formulations
GB8902424D0 (en) Medicinal formulations
GB8918809D0 (en) Pharmaceutical formulations
IE894215L (en) Pharmaceutical formulations
GB8926946D0 (en) Pharmaceutical formulations
GB8919597D0 (en) Pharmaceutical formulations
GB8919595D0 (en) Pharmaceutical formulations
GB8919456D0 (en) Pharmaceutical formulations
GB8925529D0 (en) Therapeutic formulation
GB8925530D0 (en) Therapeutic formulation
GB8925531D0 (en) Therapeutic formulation
GB8925533D0 (en) Therapeutic formulation
IE894052L (en) Formulations
GB8924635D0 (en) Formulations
GB8922288D0 (en) Formulations
GB8922917D0 (en) Formulations
GB8905015D0 (en) Formulations

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19910819

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB IT LI LU NL SE

A4 Supplementary search report drawn up and despatched

Effective date: 19920211

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB IT LI LU NL SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

17Q First examination report despatched

Effective date: 19930209

18W Application withdrawn

Withdrawal date: 19930215